Pharmaceuticals, Biotechnology and Life Sciences
Jining, Shandong Province-based Spring Pharmaceutical Group, Inc. posted net income of $4.34 million, compared to $2.78 million for the same period of the prior fiscal year.
The Superior Court of California, County of Los Angeles rejected all but one of Gilead’s arguments to dismiss the HIV/AIDS patients’ legal theories against the company’s TDF-based HIV/AIDS drug, that cause permanent damage tokidneys and bones.
ReGenTree and Ora will mutually start testing the ReGenTree’s new drug RGN-259 for the treatment of dry eye syndrome, in a clinical study named ARISE-3, based entirely on the results of a previous clinical trials, ARISE-1 and ARISE-2.
Recipharm, the contract development and manufacturing organisation (CDMO), has appointed a new director of business management for the USA and Canada, the company said in a press release on Tuesday.
Immunicum has treated the first patient in the Phase Ib/II clinical trial of its lead product in development, ilixadencel (ILIAD), in combination with checkpoint inhibitors (CPIs) in three cancer indications: head and neck cancer, non-small cell lung cancer and gastric cancer.
Basilea Pharmaceutica cahsed $5 million from Pfizer’s milestone payment triggered for selling of the antifungal Cresemba in Europe..
Pulmatrix can now begin to test in second phase its anti-fungal drug itraconaole inhaled iSPERSE formulation, to treat allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma, after the US FDA approved the company’s Investigational New Drug (IND) Application.
Innate Pharma will speed up the development of its anti-KIR3DL2 antibody, to treat T-cell lymphoma, as it has been fast tracked by the US FDA, the company said Tuesday.
Patients with certain plaque psoriasis treated with 300mg of Cosentyx for only four weeks reported in a questionnaire improvements in life quality, novartis said Monday.
U.S. Food and Drug Administration (FDA) approved AbbVie’s Imruvica (ibrutinib) combined rituximab (Rituxan) for treating adult patients with Waldenström’s macroglobulinemia (WM).